Bacteria producingβ-lactamases have become a major issue in the global public health field.To restrain the development of drug resistance and reduce the abuse of antibiotics,it is very important to rapidly identify b...Bacteria producingβ-lactamases have become a major issue in the global public health field.To restrain the development of drug resistance and reduce the abuse of antibiotics,it is very important to rapidly identify bacteria producingβ-lactamases and put forward a reasonable treatment plan.Here,an integrated microfluidic chip-mass spectrometry system was proposed for rapid screening ofβ-lactamaseproducing bacteria and optimization ofβ-lactamase inhibitor dosing concentration.The concentration gradient generator followed by an array of bacterial culture chambers,as well as micro-solid-phase extraction columns was designed for sample pretreatment before mass analysis.By using the combination system,the process of the hydrolysis of antibiotics byβ-lactamase-producing bacteria could be analyzed.To validate the feasibility,four antibiotics and two antibiotic inhibitors were investigated using three strains including negative control,SHV-1 and TEM-1 strains.SHV-1 and TEM-1 strains were successfully distinguished as theβ-lactamase producing strains.And the acquired optimal concentrations ofβ-lactamase inhibitors were in accordance with the results by that obtained from the traditional microdilution broth method.The total analysis time only needed around 2 h,which was faster than conventional methods that require a few days.The technique presented herein provides an easy and rapid protocol forβ-lactamase resistance related studies,which is important for the inhibition of antimicrobial resistance development and the reduction of antibiotics abuse.展开更多
The problem of drug resistance of Gram-negative bacteria has become increasingly serious and has aroused widespread public concern.The "super bacteria" producing New Delhi metallo-beta-lactamase(NDM-1) are r...The problem of drug resistance of Gram-negative bacteria has become increasingly serious and has aroused widespread public concern.The "super bacteria" producing New Delhi metallo-beta-lactamase(NDM-1) are resistant to almost all β-lactam antibiotics.However, clinically existing β-lactamase inhibitors are ineffective against metallo-β-lactamases(MBLs) including NDM-1.Therefore, effective NDM-1 inhibitors are urgently needed.In this study, a high-throughput screening model for NDM-1 inhibitors was optimized and used to screen NDM-1 inhibitors.As a result, IMB-XH1 was screened out as a novel NDM-1 inhibitor from 52 100 compounds of different sources.The combined use of IMB-XH1 can increase the sensitivity of E.coli BL21(DE3)(pET-30 a(+)-NDM-1) to β-lactam antibiotics.Enzymatic kinetic studies indicate that IMB-XH1 is a non-competitive inhibitor of NDM-1 and also has inhibitory activity against other MBLs such as IMP-4, ImiS and L1.As a novel NDM-1 inhibitor, its activity and mechanism of action need to be further explored.展开更多
【目的】探讨枸杞槲皮素对金黄色葡萄球菌产生的β-内酰胺酶的抑制作用机制,为临床研发β-内酰胺酶抑制剂提供基础依据。【方法】通过青霉素抑菌圈边缘试验筛选产β-内酰胺酶阳性菌株,通过药敏纸片法检测阳性菌株在32、64、128μg/mL枸...【目的】探讨枸杞槲皮素对金黄色葡萄球菌产生的β-内酰胺酶的抑制作用机制,为临床研发β-内酰胺酶抑制剂提供基础依据。【方法】通过青霉素抑菌圈边缘试验筛选产β-内酰胺酶阳性菌株,通过药敏纸片法检测阳性菌株在32、64、128μg/mL枸杞槲皮素作用下对青霉素的敏感性变化;借助多功能酶标仪检测在32、64、128、256μg/mL枸杞槲皮素处理下青霉素含量的变化,并以此来评估枸杞槲皮素对β-内酰胺酶合成及在64、128、256μg/mL枸杞槲皮素作用下对β-内酰胺酶活性的影响。通过AutoDockTools 1.5.6软件对枸杞槲皮素与BlaZ蛋白进行分子对接,采用Discovery Studio 2019 Client软件对分子对接结果进行可视化分析。【结果】从36株金黄色葡萄球菌中共筛选出23株产β-内酰胺酶阳性菌株。药敏纸片结果表明,随着枸杞槲皮素浓度的升高,阳性菌株对青霉素的敏感性增加。多功能酶标仪检测结果表明,枸杞槲皮素可以抑制β-内酰胺酶的合成,并显著抑制β-内酰胺酶的活性(P<0.05)。分子对接结果表明,枸杞槲皮素通过与BlaZ蛋白Ω-loop区域内的保守残基Asn161以氢键结合,影响BlaZ蛋白与β-内酰胺类抗生素的结合。【结论】枸杞槲皮素可以减少β-内酰胺酶的合成,还可通过降低β-内酰胺酶的活性增强青霉素的抑菌作用,具有作为β-内酰胺酶抑制剂的潜在活性,为后续开发新型β-内酰胺酶抑制剂提供了参考依据。展开更多
基金supported by Research and Development Program in Key Areas of Guangdong Province,China(No.2019B020209009)Natural Science Foundation of Guangdong Province,China(Nos.2020A1515010660 and 2022A1515011437)Shenzhen Fundamental Research and Discipline Layout project(No.JCYJ20180508152244835)。
文摘Bacteria producingβ-lactamases have become a major issue in the global public health field.To restrain the development of drug resistance and reduce the abuse of antibiotics,it is very important to rapidly identify bacteria producingβ-lactamases and put forward a reasonable treatment plan.Here,an integrated microfluidic chip-mass spectrometry system was proposed for rapid screening ofβ-lactamaseproducing bacteria and optimization ofβ-lactamase inhibitor dosing concentration.The concentration gradient generator followed by an array of bacterial culture chambers,as well as micro-solid-phase extraction columns was designed for sample pretreatment before mass analysis.By using the combination system,the process of the hydrolysis of antibiotics byβ-lactamase-producing bacteria could be analyzed.To validate the feasibility,four antibiotics and two antibiotic inhibitors were investigated using three strains including negative control,SHV-1 and TEM-1 strains.SHV-1 and TEM-1 strains were successfully distinguished as theβ-lactamase producing strains.And the acquired optimal concentrations ofβ-lactamase inhibitors were in accordance with the results by that obtained from the traditional microdilution broth method.The total analysis time only needed around 2 h,which was faster than conventional methods that require a few days.The technique presented herein provides an easy and rapid protocol forβ-lactamase resistance related studies,which is important for the inhibition of antimicrobial resistance development and the reduction of antibiotics abuse.
基金Natural Sciences Foundation of China(NSFC,Grant No.81872913)the CAMS Initiative for Innovative Medicine(Grant No.2016-I2M-1-013)+1 种基金the Fundamental Research Funds for Central Public-interest Scientific Institution(Centre for Tuberculosis)(Grant No.2016ZX310183-3)the National High-tech R&D Program(863 Program,Grant No.2015AA020911)
文摘The problem of drug resistance of Gram-negative bacteria has become increasingly serious and has aroused widespread public concern.The "super bacteria" producing New Delhi metallo-beta-lactamase(NDM-1) are resistant to almost all β-lactam antibiotics.However, clinically existing β-lactamase inhibitors are ineffective against metallo-β-lactamases(MBLs) including NDM-1.Therefore, effective NDM-1 inhibitors are urgently needed.In this study, a high-throughput screening model for NDM-1 inhibitors was optimized and used to screen NDM-1 inhibitors.As a result, IMB-XH1 was screened out as a novel NDM-1 inhibitor from 52 100 compounds of different sources.The combined use of IMB-XH1 can increase the sensitivity of E.coli BL21(DE3)(pET-30 a(+)-NDM-1) to β-lactam antibiotics.Enzymatic kinetic studies indicate that IMB-XH1 is a non-competitive inhibitor of NDM-1 and also has inhibitory activity against other MBLs such as IMP-4, ImiS and L1.As a novel NDM-1 inhibitor, its activity and mechanism of action need to be further explored.
文摘【目的】探讨枸杞槲皮素对金黄色葡萄球菌产生的β-内酰胺酶的抑制作用机制,为临床研发β-内酰胺酶抑制剂提供基础依据。【方法】通过青霉素抑菌圈边缘试验筛选产β-内酰胺酶阳性菌株,通过药敏纸片法检测阳性菌株在32、64、128μg/mL枸杞槲皮素作用下对青霉素的敏感性变化;借助多功能酶标仪检测在32、64、128、256μg/mL枸杞槲皮素处理下青霉素含量的变化,并以此来评估枸杞槲皮素对β-内酰胺酶合成及在64、128、256μg/mL枸杞槲皮素作用下对β-内酰胺酶活性的影响。通过AutoDockTools 1.5.6软件对枸杞槲皮素与BlaZ蛋白进行分子对接,采用Discovery Studio 2019 Client软件对分子对接结果进行可视化分析。【结果】从36株金黄色葡萄球菌中共筛选出23株产β-内酰胺酶阳性菌株。药敏纸片结果表明,随着枸杞槲皮素浓度的升高,阳性菌株对青霉素的敏感性增加。多功能酶标仪检测结果表明,枸杞槲皮素可以抑制β-内酰胺酶的合成,并显著抑制β-内酰胺酶的活性(P<0.05)。分子对接结果表明,枸杞槲皮素通过与BlaZ蛋白Ω-loop区域内的保守残基Asn161以氢键结合,影响BlaZ蛋白与β-内酰胺类抗生素的结合。【结论】枸杞槲皮素可以减少β-内酰胺酶的合成,还可通过降低β-内酰胺酶的活性增强青霉素的抑菌作用,具有作为β-内酰胺酶抑制剂的潜在活性,为后续开发新型β-内酰胺酶抑制剂提供了参考依据。
